Clinical Trial Update: Aliskiren and Valsartan vs Valsartan Alone in Patients With Stage II Systolic Hypertension and Type II Diabetes Mellitus [Phase 4]

View source ↗

Summary

Phase 4 trial comparing aliskiren plus valsartan versus valsartan alone in patients with stage II systolic hypertension and type 2 diabetes; results were posted…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension
• Type 2 Diabetes Mellitus

Drugs mentioned

• DIOVAN (valsartan)
• Tekturna (aliskiren)

Snippet

Sponsor: Novartis | Conditions: Hypertension | Phase 4 | Status: COMPLETED | Results posted: 2012-10-31